We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-3.07%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$46.8B
AUM Growth
+$933M
Cap. Flow
+$2.08B
Cap. Flow %
4.45%
Top 10 Hldgs %
8.13%
Holding
3,617
New
458
Increased
1,225
Reduced
1,321
Closed
452

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$255M
2
PGR icon
Progressive
PGR
+$244M
3
V icon
Visa
V
+$238M
4
LRCX icon
Lam Research
LRCX
+$201M
5
ELV icon
Elevance Health
ELV
+$190M

Sector Composition

Rank Sector Weight
1 Technology 17.88%
2 Healthcare 13.28%
3 Financials 10.32%
4 Industrials 9.79%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIW icon
3251
Highwoods Properties
HIW
$3.46B
-21,404
Closed -$655K
HLLY icon
3252
Holley
HLLY
$375M
-44,304
Closed -$134K
HOLX
3253
DELISTED
Hologic
HOLX
-97,784
Closed -$7.05M
HTCR icon
3254
HeartCore Enterprises
HTCR
$4.03M
-1,579
Closed -$57.3K
HUYA
3255
Huya Inc
HUYA
$498M
-76,524
Closed -$235K
HYPR icon
3256
Hyperfine
HYPR
$95.7M
-62,543
Closed -$55K
HZO icon
3257
MarineMax
HZO
$1.15B
-16,300
Closed -$472K
PPLI
3258
People Inc
PPLI
$2.86B
-109,410
Closed -$3.87M
IAUX
3259
i-80 Gold Corp
IAUX
$1.57B
-14,282
Closed -$6.93K
IBIT icon
3260
iShares Bitcoin Trust
IBIT
$58.3B
-381,434
Closed -$20.2M
IDN icon
3261
Intellicheck
IDN
$59.8M
-17,921
Closed -$50.2K
IDR icon
3262
Idaho Strategic Resources
IDR
$517M
-20,030
Closed -$204K
IFRX icon
3263
InflaRx
IFRX
$309M
-19,716
Closed -$48.7K
IHE icon
3264
iShares US Pharmaceuticals ETF
IHE
$1.69B
-67,400
Closed -$4.43M
IIIV icon
3265
i3 Verticals
IIIV
$301M
-52,296
Closed -$1.2M
ILCB icon
3266
iShares Morningstar US Equity ETF
ILCB
$1.31B
-37,700
Closed -$3.06M
IMOS
3267
ChipMOS TECHNOLOGIES
IMOS
$1.88B
-13,990
Closed -$263K
IMUX icon
3268
Immunic
IMUX
$225M
-15,720
Closed -$157K
INGN icon
3269
Inogen
INGN
$149M
-27,549
Closed -$253K
INTA icon
3270
Intapp
INTA
$3.16B
-17,532
Closed -$1.12M
INVE icon
3271
Identive
INVE
$69.1M
-20,944
Closed -$76.7K
IPG
3272
DELISTED
Interpublic Group of Companies
IPG
-65,948
Closed -$1.85M
IPGP icon
3273
IPG Photonics
IPGP
$3.12B
-27,556
Closed -$2M
IR icon
3274
Ingersoll Rand
IR
$31.2B
-4,100
Closed -$371K
ITA icon
3275
iShares US Aerospace & Defense ETF
ITA
$14.2B
-268,400
Closed -$39M

Similar funds

John Overdeck's Q1 2025 Portfolio in Review

As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.

  • John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
  • John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
  • John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
  • John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
  • John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
  • John Overdeck opened 458 new positions and closed 452 in Q1 2025.
  • John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.